Print Friendly

Q3 2015 BioLife Solutions, Inc. Earnings Conference Call

November 12, 2015 Biolife Solutions Q3 Conference Call
4:30 PM ET Listen to webcast


About BioLife Solutions:

BioLife Solutions develops, manufactures and markets hypothermic storage and cryopreservation solutions and precision thermal shipping products for cells, tissues, and organs. BioLife also performs contract aseptic media formulation, fill, and finish services. The Company’s proprietary HypoThermosol® and CryoStor® platform of solutions are highly valued in the biobanking, drug discovery, and regenerative medicine markets. BioLife’s biopreservation media products are serum-free and protein-free, fully defined, and are formulated to reduce preservation-induced cell damage and death. BioLife’s enabling technology provides commercial companies and clinical researchers significant improvement in shelf life and post-preservation viability and function of cells, tissues, and organs.

Alliance for Regenerative Medicine’s Stem Cell Meeting on the Mesa
October 7-9, 2015 | BioLife Solutions Presentation (pdf)

Stock Information

Stock symbol: BLFS

SEC Filings